Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024MelanomaNonmelanoma Skin CancerPediatricsMixed TopicsBusiness of Medicine
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Nonmelanoma Skin CancerMelanomaBusiness of MedicinePediatrics
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024MelanomaNonmelanoma Skin CancerPediatricsMixed TopicsBusiness of Medicine
Consider Skin Cancer, Infection Risks in Solid Organ Transplant RecipientsApril 12, 2024Nonmelanoma Skin CancerMelanomaMixed Topics
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive CancersApril 12, 2024MelanomaNonmelanoma Skin Cancer
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024MelanomaNonmelanoma Skin Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024MelanomaMixed TopicsNonmelanoma Skin CancerPediatrics
Analysis Finds Low Malignancy Rate in Pediatric Longitudinal MelanonychiaApril 8, 2024PediatricsPigmentation DisordersMelanoma
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024MelanomaNonmelanoma Skin CancerPediatrics
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Fast Facts FridayMelanomaMixed TopicsNonmelanoma Skin CancerPediatricsBusiness of Medicine
Florida Legislature Passes Free Skin Cancer Screening RequirementMarch 28, 2024MelanomaNonmelanoma Skin CancerBusiness of Medicine
Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsMelanomaNonmelanoma Skin CancerMixed TopicsBusiness of Medicine
AI in Clinical Dermatology: Consider Limitations, Current IssuesMarch 22, 2024Business of MedicineNonmelanoma Skin CancerMelanoma
